Annovis Bio is down -69.5%, or -$12.51 to $5.50.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
- Largest borrow rate increases among liquid names
- Annovis Bio Inc call volume above normal and directionally bullish
- Annovis Bio falls -9.6%
- Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results